Shuttle Pharmaceuticals Financials - Benzinga

Shuttle Pharmaceuticals Holdings Inc

SHPHNASDAQ

Trade with Public

Trade with Public

$3.92

-0.19-4.62%

近くで: Sep 28, 5:00 PM EST

$3.78

-0.33-8.03%

プレマーケット: 6:14 AM EST

決算: Q2 2026に発表されました。期中木 9 24thに決算が発表されました木 9 24th マーケット時間中。

概要ニュース業績予想イベント財務センチメント株主構成比較株式レポート

Shuttle Pharmaceuticals Financials

Shuttle Pharmaceuticals (SHPH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Shuttle Pharmaceuticals Q2 EPS $(3.10) Up From $(32.90) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.10) per share. This is a 90.58 percent increase over losses of $(32.90) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(0.43) per share. This is a 94.34 percent increase over losses of $(7.60) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q3 EPS $(1.05) Up From $(39.75) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.05) per share. This is a 97.36 percent increase over losses of $(39.75) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q2 EPS $(3.29) Up From $(24.12) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over losses of $(24.12) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.59) per share. This is a 74.73 percent decrease over losses of $(0.91) per share from the same period last year.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved